Skip to main content
Log in

Serum and C.S.F. levels of transaminases in neurological disorders

  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Summary

The levels of transaminases in the C.S.F. and the serum in forty cases of various neurological disorders were determined. In most of the cases of tuber-culous meningitis the C.S.F. levels of transaminases showed an increase corresponding to the rise in proteins and cell count. High levels were noted in cases with more severe involvement of the disease with multiple neurological deficit. Some of the cases of epilepsy showed increased contents of serum transaminases. In other cases of neurological disorders the values of C.S.F. and serum transaminases were within the normal limits or showed only a borderline elevation. It is apparent that the estimation of these enzymes in neurological disorders does not have any diagnostic value. It may, however, be possible to correlate the raised transaminase levels with brain damage and thus help to prognosticate the development of sequelae such as paralysis of the extremities and cranial nerves, spinal blocks, cerebral palsy, mental retardation, etc.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aronson, S.M. (1960). Enzyme determination in neurologic and neuromuscular disorders of infancy and childhood.Pediat. Clin. N. Amer. 7, 527.

    CAS  Google Scholar 

  • Fleisher, G.A., Wakim, K.G. and Goldstein, N.P. (1957). Glutamic oxalacetic transaminase and lactodehydrogenase in serum and C.S.F. of patients with neurological disorders.Proc. Staff. Meet. Mayo Clin. 32, 188.

    PubMed  CAS  Google Scholar 

  • Green, J.B., Oldeworiel, H., O’Doherty, D.S., Foreste, F.M. and Sanchez Longo, L.P. (1957). Cerebrospinal fluid glutamic oxaloacetic transaminase activity in neurologic diseases.Neurology,7, 313.

    PubMed  CAS  Google Scholar 

  • Katzman, R., Fishman, R.A. and Goldewsohn, E.S. (1957). Glutamic oxaloacetic transaminase activity in spinal fluid.Neurology,7, 853.

    PubMed  CAS  Google Scholar 

  • Lending, M. Slobody, L.B., and Mestern, J. (1959). Effect of convulsions on C.S.F. and plasma activity of glutamic oxaloacetic transaminase and lactodehydrogenase.Neurology,9, 672.

    PubMed  CAS  Google Scholar 

  • Miyazaki, M. (1958). Glutamic oxaloacetic transaminase in C.S.F.J. Nerve. & Ment. Dis. 126, 169.

    Article  CAS  Google Scholar 

  • Myerson, R.M., Hurwitz, J.K. and Sall, T. (1957). Serum and C.S.F. transaminase in various neurologic disorders.New Engl. J. Med. 257, 273.

    Article  PubMed  CAS  Google Scholar 

  • Siekert, R.G., Gerard, E.A., and Fleisher, G.A. (1956). Serum G.O.T. in certain neurologic and neuromuscular diseases.Proc. Staff Meet. Mayo Clinic,31, 459.

    CAS  Google Scholar 

  • Umbreit, W.W., Rahway, V.J., Kingsley, G.R., Schaffert, R.R. and Siblet, H. (1957). A colorimeteric method for transaminases in serum or plasma.J. Lab. Clin. Med. 49, 454.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

From the Department of Pediatrics, M.G.M. Medical College, Indore (M.P.).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Srivastava, G. Serum and C.S.F. levels of transaminases in neurological disorders. Indian J Pediatr 38, 27–31 (1971). https://doi.org/10.1007/BF02787646

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02787646

Keywords

Navigation